Sophion Bioscience AS

It's not clear whether Big Pharma spin-outs always deliver better returns on investment. Still, spin-outs remain an investor favorite, and in Europe are becoming the mainstay of a sustainable biopharm

Modulating ion channels via accessory proteins PO Box 2299 Bristol BS99 5YG, UK Phone: (44) 117 928 8973 Fax: (44) 117 925 2659 Web Site: www.lectustherapeutics.com Contact: Roland Kozlowski, PhD,

Automated medium- and high-throughput ion channel screening systems promise to jump start the search for ion channel modulating drugs, a vast and promising area of drug discovery. In Vivo Europe Rx lo

Recent clinical failures have left Denmark's NeuroSearch uncomfortably dependent on NS2330, a promising phase II Alzheimer's and Parkinson's treatment out-licensed to Boehringer Ingelheim. To reduce r